Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity

Nature Medicine

Volumn 2, Issue 7, 1996, Pages 800-803

  Shimomura, Iichiro ^a   Funahashi, Tohru ^a   Takahashi, Masahiko ^a   Maeda, Kazuhisa ^a   Kotani, Kazuaki ^a   Nakamura, Tadashi ^a   Yamashita, Shizuya ^a   Miura, Masakazu ^b   Fukuda, Yoji ^c   Takemura, Kaoru ^a   Tokunaga, Katsuto ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Mitsubishi Kagaku Bio Clin Labs   (Japan)

^c Otsuka Assay Laboratories   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; BODY FAT; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; VASCULAR DISEASE;

3T3 CELLS; ADIPOSE TISSUE; ANIMALS; FEMALE; HUMANS; MALE; MICE; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; VASCULAR DISEASES; VISCERA;

ANIMALIA;

EID: 15844381594     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0796-800     Document Type: Article

References (23)

1. Larsson, B. et al. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br. Med. J. 288, 1401-1404 (1984).
2. Kissebah, A.H. et al. Relation of body fat distribution to metabolic complications of obesity. J. Clin. Endocrinol. Metab. 54, 254-260 (1982).
3. Deprés, J.P. et al. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 38, 304-309 (1989).
4. Matsuzawa, Y., Tokunaga, K., Fujioka, S. & Tarui, S. Pathophysiology of visceral fat obesity. in Progress in Obesity Research, (ed. Oomura, Y.) 309-312 (John Libbey, London, 1990).
5. Nakamura, T. et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 107, 239-246 (1994).
6. Wiman, B. & Hamsten, A. The fibrinolytic enzyme system and its role in the etiology of thrombo-embolic disease. J. Biol. Chem. 259, 3644-3647 (1984).
7. Hamsten, A., Wiman, B., Faire, U.D. & Blomback, M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N. Engl. J. Med. 313, 1557-1563 (1985).
8. Wiman, E. & Hamsten, A. The fibrinolytic enzyme system and its role in the etiology of thrombotic disease. Semin. Thromb. Haemost. 26, 207-216 (1990).
9. Auwerx, J., Bouillon, R., Collen, D. & Geboers, J. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 8, 68-72 (1988).
10. Vague, P. et al. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism 35, 250-253 (1986).
11. Lucore, C.L., Fujii, S., Wun, T.C., Sobel, B.E. & Billadello, J.J. Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor. J. Biol. Chem. 263, 15845-15848 (1988).
12. Kooistra, T. et al. Plasminogen activator inhibitor 1: Biosynthesis and mRNA levels are increased by insulin in cultured human hepatocytes. Thromb. Haemost. 62, 723-728 (1989).
13. Hotamisligil, G.S., Shargill, N.S. & Spiegelman, B.M. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259, 87-91 (1993).
14. Hotamisligil, G.S., Arner, P., Caro, J.F., Atkinson, R.L. & Spiegelman, B.M. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 95, 2409-2415 (1995).
15. Spiegelman, B.M., Choy, L., Hotamisligil, G.S., Graves, R.A. & Tontonoz, P. Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. J. Biol. Chem. 268, 6823-6826 (1993).
16. Ailhaud, G., Grimaldi, P. & Negrel, R. Cellular and molecular aspects of adipose tissue development. Annu. Rev. Nutr. 12, 207-233 (1992).
17. Shimomura, I. et al. Marked reduction of acyl-CoA synthetase activity and mRNA in intra-abdominal visceral fat by physical exercise. Am. J. Physiol. 265, E44-E50 (1993).
18. Björntorp, P. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis. 10, 493-496 (1990).
19. Reaven, G.M. Role of insulin resistance in human disease. Diabetes 37, 1595-1607 (1988).
20. Tokunaga, K., Matsuzawa, Y., Ishikawa, K. & Tarui, S. A novel technique for the determination of fat by computed tomography. Int. J. Obes. 7, 437-445 (1983).
21. Fujioka, S., Matsuzawa, Y., Tokunaga, K. & Tarui, S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36, 54-59 (1987).
22. Tokunaga, K., Fukushima, M., Kemnitz, J.W. & Bray, G.A. Comparison of ventromedial and paraventricular lesions in rats that become obese. Am. J. Physiol. 251, R1221-R1227 (1986).
23. Funahashi, T. et al. Enhanced expression of rat obese (ob) gene in adipose tissues of ventromedial hypothalamus (VMH)-lesioned rats. Biochem. Biophys. Res. Commun. 211, 469-475 (1995).